Fundraising FoxBiotech Startups
11,140 companies tagged Biotech, with their investors and founders.
X-Biomedical develops GoScope, a portable digital microscope for medical use that combines augmented-reality viewing, voice control, built-in illumination, and high-definition video and image capture. It targets medical practitioners with features including multi-user viewing and simulcasting.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
XCR Diagnostics develops portable molecular diagnostic systems for rapid nucleic acid testing at the point of care. The Pyramid system delivers lab-quality results in approximately 7 minutes for infectious disease detection in hospitals, clinics, emergency rooms, and resource-limited settings.
0 investors
XDemics develops cell culture and biomanufacturing technologies for generating mammalian cells at high densities for advanced therapy production. The company's HDCR platform and related products enable researchers and GMP facilities to produce T cell, stem cell, and viral-based therapies with improved quality and consistency.
0 investors
0 investors
Xencor develops antibody-based therapeutics using its XmAb protein engineering platform, with a pipeline focused on treating cancer and other serious diseases. The company is a publicly traded biotechnology firm that engineers Fc domains and bispecific antibodies and partners with other companies to develop and market drugs.
0 investors
Xenetic Biosciences is a biopharmaceutical company developing immuno-oncology technologies for hard-to-treat cancers. Its DNase platform targets neutrophil extracellular traps (NETs) to improve existing treatments, with a systemic DNase program being advanced into the clinic as an adjunctive therapy for pancreatic carcinoma and other solid tumors.
0 investors
0 investors
XenoTherapeutics develops regenerative medicine therapies derived from genetically engineered pigs as a living donor source, aiming to replace human cadaver tissue. Its first product, realSKIN, is a living skin transplant intended to support healing after severe injury.
0 investors
0 investors